Arboviral diseases, neuroinvasive and nonneuroinvasive†
Chlamydia trachomatis infection
Cholera (toxigenic Vibrio cholerae O1 or O139)
Dengue virus infections†
Ehrlichiosis and anaplasmosis
Haemophilus influenzae, invasive disease†
Hansen’s disease (Leprosy)
Hantavirus infection, non-Hantavirus pulmonary syndrome†
Hantavirus pulmonary syndrome†
Hemolytic uremic syndrome, postdiarrheal
Hepatitis viral infections
Influenza-associated pediatric mortality
Invasive pneumococcal disease (Streptococcus pneumoniae, invasive disease)
Meningococcal disease (Neisseria meningitidis)†
Novel influenza A virus infections
Poliovirus infection, nonparalytic
Rubella, congenital syndrome
Severe acute respiratory syndrome-associated coronavirus disease (SARS-CoV)
Shiga toxin-producing Escherichia coli (STEC)
Spotted fever rickettsiosis
Streptococcal toxic shock syndrome
Toxic shock syndrome (other than streptococcal)
Typhoid fever (caused by Salmonella enterica serotype typhi)
Vancomycin-intermediate Staphylococcus aureus (VISA) infection
Vancomycin-resistant Staphylococcus aureus (VRSA) infection
Vibriosis (any species of the family Vibrionaceae, other than toxigenic Vibrio cholerae O1 or O139)
Viral hemorrhagic fever**
* This list reflects position statements approved in 2014 by CSTE for national surveillance, which were implemented in January 2015. National surveillance case definitions for these infectious diseases and conditions are available at https://wwwn.cdc.gov/nndss/conditions.
† Campylobacteriosis, Chikungunya virus disease (neuroinvasive and nonneuroinvasive), and Hantavirus infection, non-Hantavirus pulmonary syndrome were added to the notifiable disease list in 2015. For the other specified conditions, the year 2015 reflects a modified surveillance case definition for the specified diseases, as per approved 2014 CSTE position statements.
§ AIDS (Acquired Immunodeficiency Syndrome) has been reclassified as HIV stage III.
¶ Includes the following categories: primary, secondary, latent (including early latent and late latent), and late syphilis with clinical manifestations (including late benign syphilis and cardiovascular syphilis).
**As of January 1, 2015, the event code for Viral Hemorrhagic Fevers (VHF) was retired and new event codes were used to report disease-specific VHF cases.
For more information on these diseases click here: https://www.cdc.gov/mmwr/volumes/64/wr/mm6453a1.htm?s_cid=mm6453a1_w